NCT05113823

Brief Summary

This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 16, 2020

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 19, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 9, 2021

Completed
Last Updated

November 9, 2021

Status Verified

November 1, 2021

Enrollment Period

3 days

First QC Date

October 25, 2021

Last Update Submit

November 8, 2021

Conditions

Keywords

In Situ SimulationIntreprofessional TrainingHigh Fidelity Mannequin

Outcome Measures

Primary Outcomes (3)

  • rate of interprofessional communication

    improvement of interprofessional communication in transferring critically ill COVID-19 patients

    within 3 months

  • rate of skill

    improvement of skill in transferring critically ill COVID-19 patients

    within 3 months

  • rate of team work

    improvement of team work in transferring critically ill COVID-19 patients

    within 3 months

Study Arms (2)

High Fidelity Simulator

ACTIVE COMPARATOR

Subjects will receive training using high fidelity simulator

Procedure: Simulation Training

Low Fidelity Simulator

ACTIVE COMPARATOR

Subjects will receive training using low fidelity simulator

Procedure: Simulation Training

Interventions

Simulation Training using High and Low Fidelity Simulator

High Fidelity SimulatorLow Fidelity Simulator

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • in good physical condition
  • had no history of involving in COVID-19 patients care
  • willing to become study subject

You may not qualify if:

  • doesn't want to become study subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cipto Mangunkusumo Cental National Hospital

Jakarta, DKI Jakarta, 10430, Indonesia

Location

Related Publications (1)

  • Manggala SK, Tantri AR, Sugiarto A, Sianipar IR, Prasetyono TOH. In situ simulation training for a better interprofessional team performance in transferring critically ill patients with COVID-19: a prospective randomised control trial. Postgrad Med J. 2022 Aug;98(1162):617-621. doi: 10.1136/postgradmedj-2021-141426. Epub 2022 Jan 31.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 25, 2021

First Posted

November 9, 2021

Study Start

November 16, 2020

Primary Completion

November 19, 2020

Study Completion

March 15, 2021

Last Updated

November 9, 2021

Record last verified: 2021-11

Locations